Healthcare provider profile · identity verified

David A Misorski, MD

Family Practice · JOHNSON CREEK, WI · NPI 1780791285

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	831	202
Amlodipine Besylate	Amlodipine Besylate	425	107
Omeprazole	Omeprazole	349	89
Levothyroxine Sodium	Levothyroxine Sodium	305	69
Metformin Hcl Er	Metformin Hcl	301	85
Losartan Potassium	Losartan Potassium	293	83
Lisinopril	Lisinopril	290	71
Metoprolol Succinate	Metoprolol Succinate	239	63
Tamsulosin Hcl	Tamsulosin Hcl	216	51
Irbesartan	Irbesartan	209	54
Furosemide	Furosemide	205	51
Gabapentin	Gabapentin	204	52
Hydrochlorothiazide	Hydrochlorothiazide	202	62
Eliquis	Apixaban	188	41
Simvastatin	Simvastatin	175	45
Rosuvastatin Calcium	Rosuvastatin Calcium	174	54
Pantoprazole Sodium	Pantoprazole Sodium	166	38
Alendronate Sodium	Alendronate Sodium	163	38
Finasteride	Finasteride	146	34
Escitalopram Oxalate	Escitalopram Oxalate	141	34
Allopurinol	Allopurinol	132	36
Warfarin Sodium	Warfarin Sodium	129	20
Metoprolol Tartrate	Metoprolol Tartrate	125	29
Trazodone Hcl	Trazodone Hcl	125	25
Potassium Chloride	Potassium Chloride	114	24
Fluticasone Propionate	Fluticasone Propionate	102	35
Tramadol Hcl	Tramadol Hcl	98	16
Pravastatin Sodium	Pravastatin Sodium	94	22
Glimepiride	Glimepiride	92	27
Tizanidine Hcl	Tizanidine Hcl	91	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	17
Metformin Hcl	Metformin Hcl	88	23
Carvedilol	Carvedilol	85	24
Albuterol Sulfate Hfa	Albuterol Sulfate	84	46
Duloxetine Hcl	Duloxetine Hcl	83	20
Prednisone	Prednisone	79	48
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	21
Sertraline Hcl	Sertraline Hcl	76	20
Ozempic	Semaglutide	72	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	23
Glyxambi	Empagliflozin/Linagliptin	67	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	20
Doxazosin Mesylate	Doxazosin Mesylate	64	17
Benazepril Hcl	Benazepril Hcl	62	16
Ezetimibe	Ezetimibe	62	11
Memantine Hcl	Memantine Hcl	62	suppressed
Xarelto	Rivaroxaban	58	suppressed
Donepezil Hcl	Donepezil Hcl	57	suppressed
Jardiance	Empagliflozin	57	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	52	14
Famotidine	Famotidine	51	suppressed
Glipizide Er	Glipizide	51	suppressed
Spironolactone	Spironolactone	51	18
Glipizide	Glipizide	50	14
Humalog Kwikpen U-100	Insulin Lispro	49	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	42	suppressed
Mirtazapine	Mirtazapine	42	suppressed
Rybelsus	Semaglutide	42	11
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Atenolol	Atenolol	39	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	36	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	34	11
Pregabalin	Pregabalin	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Baclofen	Baclofen	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Bupropion Xl	Bupropion Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Linzess	Linaclotide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Phenobarbital	Phenobarbital	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Risperidone	Risperidone	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Meloxicam	Meloxicam	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Naproxen	Naproxen	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Cefdinir	Cefdinir	14	14
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Indapamide	Indapamide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Prolastin C	Alpha-1-Proteinase Inhibitor	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Clomipramine Hcl	Clomipramine Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levocarnitine	Levocarnitine (With Sugar)	13	suppressed
Methimazole	Methimazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Topiramate	Topiramate	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error